Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Targeting intracranial patient-derived glioblastoma (GBM) with a NIR-I fluorescent immunoconjugate for facilitating its image-guided resection RSC ADVANCES Hettie, K. S., Teraphongphom, N., Ertsey, R. D., Rosenthal, E. L., Chin, F. T. 2020; 10 (69): 42413–22
View details for DOI 10.1039/d0ra07245a
View details for Web of Science ID 000592897600049